What was recalled
In April of 2021, the U.S. Consumer Product Safety Commission (CPSC) announced a significant safety alert involving a popular topical pain relief product. The recall specifically targets Welmate Lidocaine Numbing Cream, a product manufactured and distributed by YYBA. This is not a minor issue with packaging design; it involves a fundamental failure to meet federal safety standards for child-resistant containers. If you have ever used this cream for minor aches, pains, or skin irritation, it is important to know exactly what physical item is involved so you can check your home supplies accurately.
The specific product subject to this recall is the 113-gram (which is equivalent to 4 ounces) version of Welmate Lidocaine Numbing Cream. It is packaged in a distinctive white jar that features a white cap. The label on these jars is quite colorful, incorporating blue, orange, and green design elements. Printed clearly on the front of the label are the brand name "Welmate," the active ingredient concentration "5% Lidocaine," the Welmate logo, and one of two specific Universal Product Code (UPC) numbers: 373581105045 or 373581000012. It is crucial to check these UPC codes, as they serve as a primary identifier for the affected units.
Beyond the label information, the most critical identifiers for this recall are found on the underside of the jar. Manufacturers print lot numbers and corresponding expiration dates there to track production batches. The recalled items include jars with the following specific lot numbers and expiration dates: Lot ELNC2001 (expires 05/2022), Lot ELNC2002 (expires 05/2022), Lot EL5C2001 (expires 11/2022), Lot EL5C2002 (expires 11/2022), Lot EL5C2101 (expires 11/2022), and Lot EL5C2102 (expires 11/2022). If your jar does not match these lot numbers, it is likely not part of this specific recall batch, but verifying the date on the bottom is the only way to be certain.
This product was widely available through several major retail channels before and at the time of the recall announcement on April 22, 2021. Consumers could have purchased these jars directly from YYBA’s website, wellspringmeds.com, as well as through online marketplaces including eBay, Walmart, and Amazon.com. Because the product was sold across multiple platforms, it is possible that some units are still in homes today, tucked away in medicine cabinets or under sinks, long after the recall date. The CPSC noted that YYBA and Amazon were actively notifying customers who had purchased these items directly from their respective platforms, but those who bought them through other retailers or secondary markets may not have received direct notification.
The scope of this recall is defined strictly by the packaging failure. While the cream itself contains lidocaine, a standard numbing agent, the issue is not the chemical composition but rather the container's inability to prevent access by young children. This means that any jar matching the description above, regardless of whether it has been opened or remains sealed, falls under the safety warning. The recall date of April 22, 2021, marks when the public was officially informed, but the product remained in circulation for some time prior to that. It is vital to treat this as an active safety concern until you have confirmed your product is not part of this specific lot or has been properly disposed of according to YYBA’s instructions.
The hazard, explained
At the heart of this recall is a fundamental failure in safety engineering: the packaging for the YYBA Welmate Lidocaine Numbing Cream does not meet the federal standards for child-resistant containers. To understand why this matters, it helps to look at what "child-resistant" actually means in practice. The Poison Prevention Packaging Act (PPPA) requires that certain hazardous household substances be packaged in containers that are significantly difficult for children under five years old to open or get into, while remaining reasonably easy for adults to use. The Welmate cream’s current packaging lacks the complex mechanism—such as push-and-turn caps or squeeze-and-squeeze designs—that physically prevents small hands from accessing the product. Without this barrier, a curious toddler can easily remove the lid and access the contents.
The danger lies not just in the accessibility of the jar, but in the potent nature of the ingredient inside. This product contains 5% lidocaine, a local anesthetic that works by temporarily blocking nerve signals in the area where it is applied. While effective for numbing pain in adults when used correctly, lidocaine is highly toxic if ingested or absorbed through the skin in large quantities by a small child. Because young children have a much lower body weight than adults, their bodies process medications differently and are far more susceptible to overdose. Even a small amount of this cream, which might seem harmless to an adult, can deliver a dangerous dose to a toddler.
The primary risk of poisoning occurs through two main pathways: ingestion and dermal absorption. If a child puts the cream on their skin or, worse, swallows it, the lidocaine enters their system rapidly. This can lead to serious systemic effects that go far beyond simple stomach upset. In cases of poisoning, symptoms may include drowsiness, confusion, difficulty breathing, seizures, and in severe cases, coma or death. The fact that the product is a cream rather than a pill does not mitigate the risk; creams are often appealing to children due to their texture and smell, increasing the likelihood of accidental contact. Furthermore, because the packaging is not child-resistant, there is no physical delay to stop a determined child from opening the jar. This lack of a safety barrier transforms a common household pain relief item into an immediate poisoning hazard for any household with young children.
It is important to note that while this specific recall involves lidocaine numbing cream, the principle applies to many over-the-counter and prescription medications. The CPSC mandates these packaging standards precisely because accidental ingestions are a leading cause of pediatric emergency room visits. When the packaging fails to provide the required level of protection, the responsibility shifts entirely to caregivers to ensure the product is stored in a locked or otherwise inaccessible location. However, relying on storage habits alone is risky, as children can be surprisingly resourceful in finding items left within reach. The failure to meet the child-resistant packaging requirement means that this product does not offer the passive safety protection that other compliant products do, leaving families vulnerable to accidental exposure.
Who is most at risk
The primary group facing immediate danger from this recall are young children, specifically those under the age of five. This vulnerability stems directly from the nature of the product and the specific failure identified by the Consumer Product Safety Commission (CPSC). Welmate Lidocaine Numbing Cream is designed for topical pain relief, which means it is often kept in homes where families manage minor injuries, bug bites, or skin irritations. Because these conditions frequently affect young kids, the cream is likely to be within easy reach of toddlers and infants who are naturally curious and explore their environment by putting objects in their mouths.
The core of the risk lies in the packaging defect. Under normal circumstances, pain relieving creams containing lidocaine must be sold in child-resistant containers as mandated by the Poison Prevention Packaging Act. This law exists because even small amounts of concentrated lidocaine can be toxic to a small body. A typical adult might apply a pea-sized amount safely, but a young child does not understand quantity or purpose. If they find this jar because the cap does not require special dexterity or force to open, they may ingest the entire contents or apply it extensively to their skin. Their lower body weight means that a dose considered safe for an adult can quickly become a life-threatening overdose for a child.
While children are the most acute risk, other household members are also at risk of accidental exposure. This includes teenagers who might handle the product carelessly and leave it open, or elderly individuals with limited hand strength or dexterity who may struggle to close standard caps tightly enough to prevent curious grandchildren from accessing them. The recall notes that no incidents have been reported yet, which is fortunate but does not eliminate the latent danger. The absence of current injuries simply means that, so far, the packaging has held up well enough to keep children out, or that vigilant parents have intervened before harm occurred. However, the failure to meet child-resistant standards means that protection relies entirely on adult vigilance rather than a mechanical safety barrier.
It is also important to recognize who might purchase this product and inadvertently place themselves in a risky situation. The recall indicates that these items were sold through online platforms like eBay, Walmart, and wellspringmeds.com. Buyers in these contexts may not be medical professionals but rather consumers looking for over-the-counter relief. Without the physical cue of a specialized child-resistant cap, they might underestimate the hazard level of the substance inside. They may store it in bathrooms or bedrooms where children have unsupervised access, assuming that a standard screw-top lid is sufficient protection against ingestion. The lack of visible safety features on the exterior can create a false sense of security for caregivers who are already managing multiple tasks and distractions.
How to tell if you have the recalled item
Before you take any action or contact customer service, the most critical step is confirming whether your product is actually part of this specific safety alert. Because YYBA has issued a recall for Welmate Lidocaine Numbing Cream due to packaging failures, not because the cream itself is inherently defective, it is entirely possible that you have a perfectly safe, compliant version of the same product on your shelf. To ensure you don’t dispose of a usable item or miss out on a refund for a dangerous one, you need to inspect your jar with careful attention to several distinct physical markers. Start by holding the container up to the light and examining the label closely. The recalled product is packaged in a white jar that features a distinctive combination of blue, orange, and green colors on its label. This specific color palette is a primary visual identifier, but it should not be relied upon alone.
Next, look for the specific text printed directly on that label. You must verify the presence of the brand name "Welmate" and the dosage strength clearly marked as "5% Lidocaine." Alongside these words, you should see the official Welmate logo. If any of these textual elements are missing or spelled differently, your product is likely not part of this recall. However, text can sometimes be ambiguous due to lighting or wear, so the most reliable method of identification lies in the barcodes and lot codes located on the bottom of the jar. Turn the container over and inspect the underside for printed lot numbers and their corresponding expiration dates.
The CPSC recall notice specifies that only jars with particular lot numbers are subject to this alert. You must check for one of the following exact lot number combinations: ELNC2001 (expiration date 05/2022), ELNC2002 (expiration date 05/2022), EL5C2001 (expiration date 11/2022), EL5C2002 (expiration date 11/2022), EL5C2101 (expiration date 11/2022), or EL5C2102 (expiration date 11/2022). If your jar bears a different lot number or an expiration date outside of these specific months and years, it is not included in this recall. Additionally, you can cross-reference the UPC code printed on the label; the recalled items carry either 373581105045 or 373581000012. If you purchased your product recently from major retailers like eBay, Walmart, Amazon, or the official wellspringmeds.com site, it is highly recommended that you check your order history against these specific lot numbers to confirm your status.
If you have located a jar that matches all the physical descriptions above—the white container with the blue, orange, and green label, the correct "5% Lidocaine" text, and one of the listed lot numbers—you are in possession of the recalled item. In this case, do not use it, and proceed immediately to the next steps regarding disposal and refunds. If your product does not match these criteria exactly, you can breathe a sigh of relief; your product is safe to keep using according to the label instructions.
What to do — step by step
If you have purchased the recalled YYBA Welmate Lidocaine Numbing Cream, your immediate priority is to ensure that the product does not come into contact with any children in your home. Because the packaging fails to meet the mandatory child-resistant standards required by the Poison Prevention Packaging Act, the jar does not offer the necessary protection against curious toddlers or young children who might mistake the cream for a harmless treat or lotion. Therefore, the first and most critical step you must take is to immediately stop using the product. Do not leave it out on bathroom counters, nightstands, or in any accessible location. Instead, place the jar in a secure spot that is completely out of reach and sight of children, such as a locked cabinet or a high shelf that only adults can access. This temporary storage measure buys you time to arrange for proper disposal without risking accidental exposure or ingestion, which could lead to serious poisoning. Once the product is safely secured, you need to initiate the process of returning it for a full refund. The manufacturer, YYBA, has established specific channels to handle these returns efficiently. You should contact YYBA directly to receive detailed instructions on how to dispose of the product and claim your reimbursement. You can reach their customer support team by calling their toll-free number at 866-933-6337. Their representatives are available to assist you from 10 a.m. to 6 p.m. Eastern Time, Monday through Friday. If you prefer written communication or need to send documentation, you may also email them directly at recall@wellspringmeds.com. When you contact them, be prepared to provide information about your purchase, such as the lot number and expiration date found on the bottom of the jar, to verify that your specific unit is part of this recall. Alternatively, you can visit the official website at www.wellspringmeds.com and navigate to the "Recall - Important Safety Information" page for comprehensive guidance. This online resource likely contains additional forms or FAQs that can streamline the process. It is important to note that if you purchased the product through major retailers like eBay, Walmart, or Amazon, those platforms are also conducting their own direct notification processes for customers who bought the item on their sites. While YYBA is notifying known consumers directly from these sources, checking your email inbox for a message from the retailer is a good secondary step to ensure you receive any specific return labels or instructions they may provide. Do not attempt to throw the cream in your regular household trash without following the specific disposal instructions provided by YYBA, as improper disposal could still pose a risk if another child finds it. By following these steps carefully, you protect your family’s safety and secure your refund without unnecessary hassle.Your refund, repair, or replacement options
When you encounter a product recall for a health-related item like the Welmate Lidocaine Numbing Cream, your immediate instinct might be to look for a quick fix or a simple return label. However, in this specific instance, the remedy provided by the Consumer Product Safety Commission (CPSC) and YYBA is quite particular and requires a specific sequence of actions to ensure you are fully compensated and that the product is handled safely. It is important to understand that there is no option for repair, as this is a topical cream with packaging failures, nor is there an automatic replacement sent to you. Instead, the official remedy centers on two distinct steps: safe disposal and financial reimbursement. Understanding why these steps are separated can help you navigate the process without frustration.
The first part of your "option" here is actually a responsibility regarding how you get rid of the product. YYBA has stated that consumers must contact them directly to receive instructions on how to dispose of the recalled cream. This is not merely a bureaucratic hurdle; it is a critical safety measure. Because the product contains lidocaine, a potent numbing agent, and failed to meet child-resistant packaging requirements, improper disposal could still pose a risk to children or pets if the jar ends up in a trash bin where it can be accessed. By contacting YYBA for specific disposal instructions, you ensure that the hazardous material is neutralized or handled according to safety protocols before it leaves your home. Do not simply throw the jars in your regular household trash without first seeking these guidelines, as this could inadvertently create a danger for waste management workers or others who might encounter the product.
Once you have addressed the disposal aspect, the financial remedy comes into play. YYBA is offering a full refund to all consumers who purchased the recalled Welmate Lidocaine Numbing Cream. This is a significant benefit because it removes any financial burden from you for buying a defective product. However, the process for claiming this refund depends on where you made your purchase. If you bought the product on eBay, Walmart, or wellspringmeds.com, YYBA is actively notifying all known consumers who purchased the item. Similarly, if you purchased it through Amazon, Amazon is directly notifying its customers. This direct notification system is designed to make the process as seamless as possible for you. You do not need to hunt down proof of purchase in most cases, provided you were one of the identified buyers.
To initiate this process or to get the necessary disposal instructions if you have not yet been contacted, you must reach out to YYBA directly. They have established multiple channels for you to connect with them. You can call their toll-free number at 866-933-6337, which is available from 10 a.m. to 6 p.m. ET, Monday through Friday. This phone line is your primary resource for asking questions about the refund amount, the specific disposal methods, or any confusion regarding the recall notice. Alternatively, you can send an email to recall@wellspringmeds.com if you prefer written communication or need to provide additional details. For those who prefer digital self-service, YYBA has set up a dedicated section on their website at www.wellspringmeds.com. You should navigate to this site and click on the link labeled "Recall - Important Safety Information." This page likely contains the most comprehensive instructions, including any forms you might need to fill out to process your refund. By following these steps, you ensure that you are not only getting your money back but also contributing to public safety by properly handling the recalled items.
What can happen if you ignore it
It is completely understandable why you might hesitate to throw away a product you have already purchased. Perhaps the cream was sitting in your medicine cabinet for weeks, and the effort to contact customer service, package up the jar, and ship it back feels like an unnecessary hassle. You might think, "I haven't used it yet," or "It's just sitting on the shelf; what is the real risk?" While no incidents have been reported with this specific batch of Welmate Lidocaine Numbing Cream as of the recall date in April 2021, ignoring a safety recall for a topical anesthetic is not a harmless act of convenience. It is an active gamble with the health and safety of everyone in your household, particularly young children.
The core issue here is not that the cream itself is inherently toxic when used correctly by an adult, but that its packaging fails to protect against accidental exposure. The Poison Prevention Packaging Act requires certain hazardous substances to be packaged in ways that are difficult for children under five years old to open. Because this specific jar does not meet those rigorous standards, it essentially offers no barrier to a curious toddler. If you ignore the recall and leave the product within reach, a child could easily twist off the white cap, which requires little strength or dexterity. Once the lid is off, the cream becomes immediately accessible.
If a young child ingests the cream or applies it to their skin in large quantities, the consequences can be severe and potentially life-threatening. Lidocaine is a powerful local anesthetic that works by blocking nerve signals. In adults, small amounts are safe and effective for numbing pain. However, children have smaller body mass and different metabolic rates, meaning they are far more sensitive to the drug's effects. Accidental ingestion can lead to lidocaine poisoning, which affects the central nervous system and the heart. Early signs of poisoning may include dizziness, confusion, or drowsiness, but these can rapidly progress to serious medical emergencies such as seizures, irregular heartbeat, respiratory failure, and even death if not treated immediately.
Beyond the risk of ingestion, applying a high-concentration numbing cream to a child’s skin without supervision is equally dangerous. It can cause chemical burns or severe allergic reactions in sensitive skin. Furthermore, because the product is designed to numb sensation, a child might not realize they have been harmed until significant tissue damage has occurred. By ignoring this recall, you are leaving a potent medical substance in a container that looks like ordinary packaging, removing the critical safety layer intended to prevent exactly this scenario. The peace of mind that comes from knowing your home is safe for exploring toddlers is worth far more than the convenience of keeping an unopened jar.
Staying safe: broader tips
While this specific recall addresses a failure in packaging compliance for a topical numbing cream, the underlying principle applies to nearly every household containing children or individuals who may be vulnerable to accidental ingestion. The primary takeaway here is that "child-resistant" is a regulatory standard, not a guarantee of safety if stored improperly. Even products with compliant packaging can be opened by determined toddlers or curious pets. Therefore, your first line of defense should always be strategic storage. Never assume that a high shelf is safe; young children are expert climbers and will investigate any surface within their reach. Instead, store all medications, topical analgesics containing lidocaine or benzocaine, and household chemicals in locked cabinets or containers that require significant dexterity to open. This creates a physical barrier that accounts for the unpredictability of human behavior.
It is also crucial to understand that products often share similar packaging across different brands, which can lead to dangerous confusion. A jar that looks like food, candy, or even a cosmetic product from a distance can contain potent chemicals. Always keep items in their original containers with the original labels intact. Transferring substances into unmarked jars, water bottles, or food containers is one of the most common causes of accidental poisoning because it removes the critical warning information and safety cues that might otherwise deter a child. If you must transfer a product for travel, ensure the new container is clearly marked and kept separate from any consumables.
Regularly auditing your home for potential hazards is another proactive step you can take. Set aside time each month to check the expiration dates and condition of first-aid supplies. Expired creams may degrade in ways that make them less effective or, in rare cases, more irritating to the skin, but more importantly, an expired product sitting out on a counter invites use by those who might not otherwise seek it out. Use this time to verify that your emergency numbers are up to date and that you know how to contact Poison Control (1-800-222-1222 in the U.S.). They can provide immediate, expert guidance tailored to the specific substance ingested.
Finally, stay informed about product safety without letting fear dictate your daily life. Sign up for recall alerts from the Consumer Product Safety Commission (CPSC) and the FDA. These agencies post updates regularly, and having this information at your fingertips allows you to act quickly if a product you own is flagged. Remember that most products are safe when used as directed; the goal of these tips is not to create anxiety but to build a habit of mindful storage and awareness that protects your family from rare but serious accidents.
